| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |